Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Indices adjust divisors to reflect corporate actions and maintain continuity. This note covers the main reasons these changes occur.
28,369 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
The YieldMax NVDA Option Income Strategy ETF has drawn attention for its high advertised yield, but market dynamics a...
South Korea’s KOSPI just suffered a sharp, double-digit drop as rate fears and regional tensions rattled markets. US ...
AI-driven tools are accelerating in mortgage lending and brokerage work, raising the bar for service. The industry ag...
AI’s endless appetite for compute and memory is shifting demand away from PCs. Prices rise, supply tightens, and inve...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
As bitcoin oscillates, MSTY investors confront a structural risk tied to the ETF’s option strategy. The fund’s income...
Wall Street embraces a bold forecast for humanoid robots and the physical AI stack, fueling fresh bets on Nvidia, Tes...
Investors read rising short-term yields and a cautious long end as the June FOMC nears, signaling how the trillion me...
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Six weeks of fund outflows from US spot BTC ETFs weigh on Bitcoin as the price drops to 21-month lows. Long-term hold...
A defensive utility ETF is gaining attention as AI infrastructure ramps up, potentially making this “boring” ETF one ...